Clinical Trials in Bodmin, United Kingdom
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
Schizophrenia
Karuna Therapeutics, Inc., a Bristol Myers Squibb company280 enrolled175 locationsNCT05304767
Recruiting
Neuropsychiatric Research Databases for People With Intellectual Disabilities and Epilepsy (REFINE)
Learning DisabilityEpilepsyIntellectual Disability
University of Plymouth600 enrolled3 locationsNCT06780501